课题基金 / 基金详情

Study on the extrinsic blood coagulation

Study on the extrinsic blood coagulation
外源性血液凝固研究
批准号:
03680151
负责人:
MIYATA Toshiyuki
金额:
$1.22万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1991
资助国家:
日本
项目状态:
已结题
起止时间:
1991 至 1992

项目摘要

项目成果

MIYATA Toshiyuki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The extracellular domain of human tissue factor (TF, amino acids 1-217) was expressed in Saccharomyces cerevisiae, using the inducible yeast acid phosphatase promoter and the yeast invertase signal sequence to direct its secretion into the culture broth. Two active soluble forms sTF_<alpha> (high molecular weight form) and sTFbeta (low molecular weight form) were purified, the yield being approximately 10 and 1 mg/liter of culture supernatant, respectively. sTF_<alpha> had an apparent molecular mass of 150 kDa on SDS-polyacrylamide gel electrophoresis and contained more than 200 residues of mannose/mol of protein. sTFbeta had an apparent molecular mass of 37 kDa and contained 22 residues of mannose/mol of protein. N-Glycosidase F treatments of both rTFs reduced the apparent molecular mass to 35 kDa. The amino-terminal sequences and amino acid compositions of sTF_<alpha> and sTFbeta were consistent with those deduced from the cDNA sequence, thereby indicating that the difference in molecular mass is caused by heterogeneity of oligosaccharide structures. Of these recombinant TFs, sTFbeta enhanced factor VIIa-amidolytic activity 40-fold toward the chromogenic substrate and 147-fold toward the fluorogenic substrate, affecting mainly the kcat value. The enhancement was comparable with that of TF purified from human placenta. The TF-mediated enhancement of factor VIIa-amidolytic activity was inhibited by heparin-activated antithrombin III, forming a high molecular weight complex. As treatment of sTFbeta with denaturants such as guanidine hydrochloride or urea led to a biphasic loss of the activity, the extracellular domain of TF probably consists of two discrete domains. This expression system provides a significant amount of the extracellular domain of TF so that studies of interactions with factor VII are feasible.
期刊论文(25)
专著(0)
科研奖励(0)
会议论文
H.TSUDA: "Analysis of intrinsic tibrinolysis in human plasma induced by dcxtran sulfate" Thromb Haemost. 67. 440-444 (1992)
H.TSUDA:“由 dcxtran 硫酸盐诱导的人血浆中的内在纤维蛋白溶解分析” Thromb Haemost。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
宮田 敏行: "日本血栓止血学会誌,第IX因子異常症" 日本血栓止血学会, 11 (1991)
Toshiyuki Miyata:“日本血栓和止血学会杂志,因子 IX 异常”日本血栓和止血学会,11(1991)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Y.Takayenoki, T.Muta, T.Miyata and S.Iwanaga: "cDNA and amino acid sequences of bovine tissue factor" Biochem. Biophys. Res. Commun. 181. 1145-1150 (1991)
Y.Takayenoki、T.Muta、T.Miyata 和 S.Iwanaga:“牛组织因子的 cDNA 和氨基酸序列”Biochem。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
T.Miyata, R.Aruga, H.Umeyama, A.Bezeaud, M.C.Guillin and S.Iwanaga: "Prothrombin Salakta : Substitution of glutamic acid-466 by alanine reduces the fibrinogen clotting activity and the esterase activity" Biochemistry. 31. 7457-7462 (1992)
T.Miyata、R.Aruga、H.Umeyama、A.Bezeaud、M.C.Guillin 和 S.Iwanaga:“凝血酶原 Salakta:用丙氨酸替代谷氨酸 466 可降低纤维蛋白原凝血活性和酯酶活性”生物化学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
24
    Genetic background of thrombophilia using third generation DNA sequencing
    Production and analysis of Adamts13-Bac-TRAP mice that express fluorescent protein EGFP driven by Adamts13 promoter
    Thrombosis due to dysfunction of anticoagulant activity and strategy for prevention of thrombosis
    A Comprehensive Study of Production, Rice milling, Export and Consumption of Thai Jasmine Rice
    • 批准号:
      18530197
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.68万
    • 财政年份:
      2006
    • 负责人:
      MIYATA Toshiyuki
    • 依托单位:
    海外基金